These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 38068409

  • 21. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis.
    Nagarkar DR, Poposki JA, Tan BK, Comeau MR, Peters AT, Hulse KE, Suh LA, Norton J, Harris KE, Grammer LC, Chandra RK, Conley DB, Kern RC, Schleimer RP, Kato A.
    J Allergy Clin Immunol; 2013 Sep; 132(3):593-600.e12. PubMed ID: 23688414
    [Abstract] [Full Text] [Related]

  • 22. Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results.
    Bachert C, Laidlaw TM, Cho SH, Mullol J, Swanson BN, Naimi S, Classe M, Harel S, Jagerschmidt A, Laws E, Ruddy M, Praestgaard A, Amin N, Mannent LP.
    Ann Otol Rhinol Laryngol; 2023 Dec; 132(12):1649-1661. PubMed ID: 37322842
    [Abstract] [Full Text] [Related]

  • 23. Levels of eicosanoids in nasal secretions associated with nasal polyp severity in chronic rhinosinusitis.
    Nordström A, Jangard M, Svedberg M, Ryott M, Kumlin M.
    Prostaglandins Leukot Essent Fatty Acids; 2022 Sep; 184():102474. PubMed ID: 35917595
    [Abstract] [Full Text] [Related]

  • 24. Regulation of platelet-activating factor-mediated interleukin-6 promoter activation by the 48 kDa but not the 45 kDa isoform of protein tyrosine phosphatase non-receptor type 2.
    Hamel-Côté G, Lapointe F, Véronneau S, Mayhue M, Rola-Pleszczynski M, Stankova J.
    Cell Biosci; 2019 Sep; 9():51. PubMed ID: 31289638
    [Abstract] [Full Text] [Related]

  • 25. Platelet-activating factor in late asthmatic response.
    Nakamura T, Morita Y, Kuriyama M, Ishihara K, Ito K, Miyamoto T.
    Int Arch Allergy Appl Immunol; 1987 Sep; 82(1):57-61. PubMed ID: 3804454
    [Abstract] [Full Text] [Related]

  • 26. New transcriptome and clinical findings of platelet-activating factor in chronic spontaneous urticaria: Pathogenic and treatment relevance.
    Andrades E, Clarós M, Torres JV, Nonell L, González M, Curto-Barredo L, Rozas-Muñoz E, Gimeno R, Barranco C, Pujol RM, Izquierdo I, Giménez-Arnau AM.
    Biofactors; 2022 Nov; 48(6):1284-1294. PubMed ID: 35927787
    [Abstract] [Full Text] [Related]

  • 27. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.
    Gao T, Yu Y, Cong Q, Wang Y, Sun M, Yao L, Xu C, Jiang W.
    BMC Cancer; 2018 Oct 19; 18(1):999. PubMed ID: 30340558
    [Abstract] [Full Text] [Related]

  • 28. Increased expression of factor XIII-A in patients with chronic rhinosinusitis with nasal polyps.
    Takabayashi T, Kato A, Peters AT, Hulse KE, Suh LA, Carter R, Norton J, Grammer LC, Tan BK, Chandra RK, Conley DB, Kern RC, Fujieda S, Schleimer RP.
    J Allergy Clin Immunol; 2013 Sep 19; 132(3):584-592.e4. PubMed ID: 23541322
    [Abstract] [Full Text] [Related]

  • 29. Quantification of distinct molecular species of platelet activating factor in ulcerative colitis.
    Thyssen E, Turk J, Bohrer A, Stenson WF.
    Lipids; 1996 Mar 19; 31 Suppl():S255-9. PubMed ID: 8729129
    [Abstract] [Full Text] [Related]

  • 30. Effects of Omalizumab Treatment in Patients With Recalcitrant Nasal Polyposis and Mild Asthma: A Multicenter Retrospective Study.
    Armengot-Carceller M, Gómez-Gómez MJ, García-Navalón C, Doménech-Campos E, Muñoz-Fernández N, Miguel AG, Marco-Algarra J, Palop-Cervera M, Piñero AG.
    Am J Rhinol Allergy; 2021 Jul 19; 35(4):516-524. PubMed ID: 33153272
    [Abstract] [Full Text] [Related]

  • 31. Role of messenger RNA expression of platelet activating factor and its receptor in porcine in vitro-fertilized and cloned embryo development.
    Lee SH, Kim DY, Nam DH, Hyun SH, Lee GS, Kim HS, Lee CK, Kang SK, Lee BC, Hwang WS.
    Biol Reprod; 2004 Sep 19; 71(3):919-25. PubMed ID: 15151927
    [Abstract] [Full Text] [Related]

  • 32. Antiobese function of platelet-activating factor: increased adiposity in platelet-activating factor receptor-deficient mice with age.
    Sugatani J, Sadamitsu S, Yamaguchi M, Yamazaki Y, Higa R, Hattori Y, Uchida T, Ikari A, Sugiyama W, Watanabe T, Ishii S, Miwa M, Shimizu T.
    FASEB J; 2014 Jan 19; 28(1):440-52. PubMed ID: 24100020
    [Abstract] [Full Text] [Related]

  • 33. Airway hyperresponsiveness in transgenic mice overexpressing platelet activating factor receptor is mediated by an atropine-sensitive pathway.
    Nagase T, Ishii S, Shindou H, Ouchi Y, Shimizu T.
    Am J Respir Crit Care Med; 2002 Jan 15; 165(2):200-5. PubMed ID: 11790655
    [Abstract] [Full Text] [Related]

  • 34. Asthma Is the Dominant Factor for Recurrence in Chronic Rhinosinusitis.
    Sella GCP, Tamashiro E, Sella JA, Aragon DC, Mendonça TN, Arruda LKP, Anselmo Lima WT, Valera FCP.
    J Allergy Clin Immunol Pract; 2020 Jan 15; 8(1):302-309. PubMed ID: 31425833
    [Abstract] [Full Text] [Related]

  • 35. Renal allograft platelet activating factor synthesis during acute cellular rejection.
    Mangino MJ, Anderson CB, Murphy MK, Turk J.
    J Lipid Mediat; 1991 Jan 15; 4(1):69-81. PubMed ID: 1893087
    [Abstract] [Full Text] [Related]

  • 36. Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps and airway hypersensitiveness: A pilot study.
    Chen F, Hong H, Sun Y, Hu X, Zhang J, Xu G, Zhao W, Li H, Shi J.
    Ann Allergy Asthma Immunol; 2017 Oct 15; 119(4):310-316.e2. PubMed ID: 28870448
    [Abstract] [Full Text] [Related]

  • 37. [Nasal provocation with increased ASA dose: improved "non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated disease" (N‑ERD) detection rate in chronic rhinosinusitis patients].
    Förster-Ruhrmann U, Behrbohm W, Pierchalla G, Szczepek AJ, Fluhr JW, Olze H.
    HNO; 2019 Aug 15; 67(8):620-627. PubMed ID: 31069402
    [Abstract] [Full Text] [Related]

  • 38. Clinical Characteristics of Patients with Chronic Rhinosinusitis without Nasal Polyps in an Academic Setting.
    Benjamin MR, Stevens WW, Li N, Bose S, Grammer LC, Kern RC, Tan BK, Conley DB, Smith SS, Welch KC, Schleimer RP, Peters AT.
    J Allergy Clin Immunol Pract; 2019 Mar 15; 7(3):1010-1016. PubMed ID: 30368005
    [Abstract] [Full Text] [Related]

  • 39. Consumption of plant extract supplement reduces platelet activating factor-induced platelet aggregation and increases platelet activating factor catabolism: a randomised, double-blind and placebo-controlled trial.
    Gavriil L, Detopoulou M, Petsini F, Antonopoulou S, Fragopoulou E.
    Br J Nutr; 2019 May 15; 121(9):982-991. PubMed ID: 30940217
    [Abstract] [Full Text] [Related]

  • 40. Role of the platelet-activating factor and its receptor in the proliferative regulation of bovine ovarian granulosa cells.
    Viergutz T, Löhrke B.
    Cell Prolif; 2007 Dec 15; 40(6):949-60. PubMed ID: 18021181
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.